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rosophila melanogaster hemocytes are highly mo-
tile macrophage-like cells that undergo a stereotypic 
pattern of migration to populate the whole embryo 
by late embryogenesis. We demonstrate that the migratory 
patterns of hemocytes at the embryonic ventral midline are 
orchestrated by chemotactic signals from the PDGF/VEGF 
ligands Pvf2 and -3 and that these directed migrations 
  occur independently of phosphoinositide 3-  kinase (PI3K) 
signaling. In contrast, using both laser ablation and a 
novel wounding assay that allows localized treatment with 
Introduction
During  Drosophila melanogaster embryogenesis, hemocytes 
derive exclusively from head mesoderm at around 2 h after gas-
trulation (stage 10). From this point of origin, these cells mi-
grate along stereotypical routes to populate the whole embryo 
by stage 17 (Tepass et al., 1994). It has previously been shown 
that the developmental migration of these cells is dependent on 
the expression of the VEGF/PDGF ligands Pvf1, -2, and -3 
(Cho et al., 2002). The PDGF/VEGF receptor (PVR) is ex-
pressed in hemocytes (Heino et al., 2001), and pvr mutant em-
bryos fail to exhibit normal hemocyte migrations, resulting in 
an accumulation of these cells at their head end (Cho et al., 
2002; Sears et al., 2003). A recent study has demonstrated a role 
of PVR in controlling anti-apoptotic cell survival of embryonic 
hemocytes (Bruckner et al., 2004) and suggests that the defect 
in hemocyte distribution observed in the mutant is largely due 
to high numbers of hemocytes undergoing apoptosis and be-
coming engulfed by their neighbors. However, this study also 
showed that Pvr expression within hemocytes is required for the 
directed migration of a subset of these cells that enter the 
  extended germ during normal development (Bruckner et al., 
2004), suggesting that this population of hemocytes may well 
be using Pvf signals as a chemoattractant to guide their migra-
tions. Additionally, ectopic expression of Pvf2 within the em-
bryo has been shown to be suffi  cient to induce a chemotactic 
response from embryonic hemocytes (Cho et al., 2002).
In addition to migrating along developmental pathways, 
embryonic hemocytes have been shown to migrate toward a 
  laser-induced wound in a process that resembles the vertebrate 
infl  ammatory response. For a hemocyte to chemotax toward a 
chemotactic source, be it a wound or a guidance cue expressed 
along developmental migration routes, it has to be able to sense 
a chemotactic gradient and polarize in alignment with that 
 gradient. Studies using Dictyostelium discoideum and mammalian 
neutrophils have demonstrated that the phosphoinositides 
PtdIns(3,4,5)P3 (PIP3) and PtdIns(3,4)P2 (PIP2) are key signal-
ing molecules that become rapidly and highly polarized in cells 
that are exposed to a gradient of chemoattractant (Stephens 
et al., 2002; Weiner, 2002; Merlot and Firtel, 2003). In these 
  actively chemotaxing cells, phosphoinositide 3-kinases (PI3Ks) 
rapidly translocate from the cytosol to the membrane at the leading 
edge of the cell, whereas phosphatase and tensin homologue 
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(PTEN) dissociates from the leading edge and becomes re-
stricted to the sides and the rear. The difference in localization 
of these two enzymes leads to localized PIP3 production at the 
leading edge of the cell (Funamoto et al., 2002; Iijima and 
Devreotes, 2002). Down- or up-regulation of PIP3 by deletion 
of PI3Ks or of PTEN, respectively, results in severely reduced 
effi  ciency of chemotaxis (Funamoto et al., 2002). Though PI3K 
has been shown to be important for cell motility using these 
model systems, its role for single-cell chemotaxis in vivo in a 
multicellular organism has yet to be clarifi  ed. D. melanogaster 
has one class I PI3K, Dp110 (Leevers et al., 1996), whose role 
in cell growth control and cell survival has been well character-
ized (Leevers et al., 1996; Weinkove et al., 1999; Scanga et al., 
2000); however, no role in cell migration and chemotaxis in 
D. melanogaster for this protein has been shown.
In this study, we have analyzed the developmental migra-
tions of hemocytes and characterized in detail their migration 
patterns along the ventral midline. Our quantitative analysis 
shows that ventral midline hemocytes undergo a rapid lateral 
migration, during which they are highly polarized. We show that 
Pvf2 and -3 expression in the central nervous system (CNS), 
and Pvf2 alone in the dorsal vessel, are essential for directing 
the migration of hemocytes along these structures, and a de-
crease in expression of these ligands in the CNS is essential for 
the normal lateral migration of hemocytes in this region. We 
have also analyzed the function of PI3K in hemocytes. Using 
both dominant-negative PI3K–expressing hemocytes and the 
specifi  c PI3K inhibitory drug LY294002, we show that PI3K is 
not required for the Pvf-dependent normal dispersal of hemo-
cytes during   development but is essential for chemotaxis toward 
wounds. Additionally, we show that hemocyte chemotaxis to-
ward wounds is dependent on actin polymerization but that PI3K 
is not required for lamellipodial formation and instead appears 
to be required to sense a chemotactic gradient from a wound and 
polarize the hemocyte accordingly. Our results demonstrate that 
at least two separate mechanisms operate in D. melanogaster 
embryos to direct hemocyte migration and show that although 
PI3K is crucial for hemocytes to sense a chemotactic gradient 
from a wound, it is not required to sense the Pvf growth factor 
signals that coordinate their developmental migrations along the 
ventral midline and dorsal vessel during embryogenesis.
Results
Developmental dispersal of hemocytes 
at the embryonic ventral midline follows 
a segmental pattern
It has previously been shown that in the developing D. melano-
gaster embryo, hemocytes derive exclusively from the head me-
soderm and from this origin migrate along invariant pathways to 
populate the whole embryo by stage 17 (Tepass et al., 1994). One 
major migration route is along the ventral midline, where hemo-
cytes come into close contact with the cells of the CNS midline 
and the neighboring ventral epidermis. To understand more fully 
the dynamics of hemocytes during their developmental migra-
tions, we analyzed the migration of these ventral midline hemo-
cytes using live time-lapse imaging of embryos expressing GFP 
solely in the hemocytes driven by the hemocyte-specifi  c srpHemo-
GAL4 driver (Bruckner et al., 2004). At stage 12 of development, 
hemocytes are clustered together at anterior and posterior ends 
of the midline and express few lamellipodia. Some protrusive 
structures can be seen on the leading hemocytes as they migrate 
along the CNS at a rate of 0.4 μm/min and appear to engulf 
Figure 1.  Developmental dispersal of hemocytes at the ventral midline. 
(A) Ventral aspect of a pxnGAL4 UAS-GFP embryo at stage 12, showing 
hemocytes as they migrate along the ventral midline from anterior to posterior. 
(B) High-magniﬁ  cation detail of hemocytes at this stage reveals that cells 
are clustered together and exhibit only a few protrusions (arrow). 
(C) Ventral view of pxnGAL4 UAS-GFP embryos at stage 16. (D) High 
magniﬁ  cation of the same embryo reveals that these ventrally placed he-
mocytes are much larger than early hemocytes (compare with B), exhibit-
ing impressive ﬁ  lopodia and lamellipodia. (E) Stills from a time-lapse video 
show hemocyte dispersal between Stages 14.5 and 15.5 of development. 
In all images, anterior is up and posterior is down. At the beginning of this 
video, the majority of hemocytes are positioned in a single line along the 
midline (i). Over the next 150 min of development, individual hemocytes 
leave the midline and migrate laterally to form the two more laterally 
placed populations seen at stage 16 (v). (F) Superimposing the migratory 
paths of all hemocytes that leave the midline shows this process to conform 
to a pattern with hemocytes migrating away from the midline at a 90° an-
gle and leaving from spatially reiterated exit points (i and v, colored circles). 
Throughout this movement. midline hemocytes favor these exit points 
and often clump together at these locations (iii, arrows). A hemocyte can 
be seen at each of these locations once the migration is complete (v). Indi-
vidual hemocytes are labeled with colored numbers as they migrate later-
ally, with the color corresponding to the exit point from which they left the 
midline. Elapsed time in minutes is indicated in the lower right corner. 
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debris along the route (Fig. 1, A and B). At stage 16 of develop-
ment, hemocytes occupy three parallel lines running anterior to 
posterior along the embryonic ventral midline, as opposed to a 
single line along the midline at stage 14, with the more laterally 
placed hemocytes residing in the extracellular space along the 
lateral margins of the CNS (Fig. 1 C). Live confocal analysis of 
hemocytes between these developmental stages reveals that this 
distribution arises from the rapid lateral migration of a subset 
of midline hemocytes, which individually leave the midline and 
occupy these more lateral positions (Fig. 1 E and Video 1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200508161/DC1). 
High-magnifi  cation imaging of these midline hemocytes at stage 
16 reveals that, in contrast to the early stage hemocytes, these 
cells exhibit large fi  lopodia and lamellipodia, extending 20 μm 
away from the cell body (Fig. 1 D).
To investigate more thoroughly the pattern of the charac-
teristic lateral migration observed between stages 14 and 16, we 
used time-lapse confocal microscopy to track the paths taken by 
individual hemocytes as they performed this movement. Super-
imposing all hemocyte tracks from individual embryos shows 
that this movement conforms to a strict segmented pattern where 
hemocytes leave the ventral midline from spatially reiterated exit 
points and perform a 90° movement from the midline to arrive at 
a defi  ned lateral area (Fig. 1 F). While in the ventral midline, he-
mocytes aggregate in clusters that correspond to the position of 
the exit points, where cells initiate their lateral migrations (Fig. 
1 E). Closer analysis of individual tracks shows that before their 
lateral movement, hemocytes appear to move up and down the 
ventral midline between the clusters and after lateral migration, 
to a lesser extent, along the lateral rows (Fig. 2 A). To further 
  analyze this migration pattern, we quantifi  ed the directionality, 
velocity, and polarity of individual hemocytes while (1) moving 
within the ventral midline before lateral migration and (2) under-
going the lateral migration. To carry out this quantifi  cation, we 
focused our analysis on the most posterior clusters of hemocytes 
in each embryo examined (Fig. 1 E, circled area).
The directionality of hemocyte movement was calculated 
by applying a ratio between the shortest distance possible and 
the actual distance traversed by hemocytes. As expected from 
the plotted tracks, the movement during lateral migration is 
highly directional, showing an mean of 85.6% (±13.1; n = 46) 
directionality (Fig. 2 A, red track). If the same ratio is applied to 
the path of the same hemocyte before this lateral migration, 
while in the ventral midline, the mean directionality observed is 
much lower (29.6 ± 18.2%; n = 35; Fig. 2 A, blue track). Quan-
tifying the speed of migration, we noted that during the lateral 
movement, the velocity of migration undergoes a sharp increase, 
with the mean velocity for lateral migrating hemocytes being 
1.8 μm/min (±0.8; n = 46), as opposed to 1.1 μm/min (±0.5; 
n = 35) for hemocytes within the midline. Laterally migrating 
Figure 2. Quantiﬁ  cation of directionality, velocity, and polarity of hemocytes during lateral migration. (A) A typical path of a hemocyte performing lateral 
migration from the midline. Three distinct phases (a, b, and c) can be identiﬁ  ed. Before starting the lateral migration, while in the midline, the hemocyte 
moves between adjacent exit points before adopting a more random path with constant changes in direction (blue path). This is followed by the lateral mi-
gration (red path) displaying high directionality (calculated by applying a ratio between the real distance traversed by the hemocytes and the shortest pos-
sible distance shown by the broken white line). On arrival at its destination, the hemocyte returns to a more random directional behavior (yellow path). 
(B) The same path represented by dots marking the hemocyte position at each time point shows the corresponding change in velocity of the hemocyte during 
lateral migration (distance between dots corresponds to velocity). (C) Confocal image of ventral aspect of a srpHemoGAL4 UASGFP embryo during lateral 
hemocyte migration. (D) Stills from a time-lapse video showing lateral migration of the hemocyte (C, box 1). The hemocyte has been artiﬁ  cially divided into 
quadrants (1, 2, 3, and 4) corresponding to posterior medial, anterior medial, anterior lateral, and posterior medial, respectively. The outline of the cell 
has been traced to allow measurement of protrusive area. As the hemocyte migrates laterally from the midline, it extends a large membrane rufﬂ  e from its 
leading edge and displays little or no protrusions on its medial side. (E) Graph showing values for protrusive area in each quadrant plotted against time 
shows the difference between protrusive area at the lateral side of the cell (pink and purple lines) when compared with the medial side (blue and yellow 
lines). (F) Stills from a time-lapse video showing protrusion dynamics of hemocyte (C, box 2). This hemocyte remains in the midline and displays a more ran-
dom distribution of membrane rufﬂ  es, with protrusions rarely remaining in the same cell quandrant for >2 min. Elapsed time is indicated in the corner. 
Bars: (C) 20 μm; (D and F) 50 μm.JCB • VOLUME 173 • NUMBER 3 • 2006  408
hemocytes not only move faster but also have a more constant 
speed and rarely stall during the migration, in contrast with he-
mocytes in the ventral midline clusters, which often pause be-
tween periods of intense movement before they migrate laterally 
or into another cluster (Fig. 2 B).
The increase in speed and directionality of hemocytes 
during their lateral migration suggests that during this rapid 
movement, these cells are highly polarized. Actively migrating 
cells exhibit polarity by extending protrusions in the direction 
of migration, forming a persistent leading edge with an in-
creased protrusive activity when compared with that of the cell 
rear. To quantify the polarity of these migrating hemocytes, we 
artifi  cially divided individual hemocytes into four quadrants 
(corresponding to anterior lateral, anterior medial, posterior lat-
eral, and posterior medial) and measured the protrusive area in 
each of these quadrants. We found that during the lateral move-
ment, the combined lateral protrusive area of a migrating hemo-
cyte was, on average, 212 μm
2 (±49; n = 6), which is 10 times 
larger than that of the medial side (mean of 21 μm
2 [±10]; Fig. 2, 
D and E). This demonstrates that these hemocytes are highly 
polarized along the medial lateral embryonic axis, displaying a 
robust and persistent leading edge at their lateral aspect through-
out the lateral migration. In contrast, when the same quantita-
tive analysis was performed on hemocytes that remain in the 
ventral midline, no such persistent polarization was observed. 
Although cells from the midline are able to extend protrusions 
similar in dimension to those described for hemocytes migrat-
ing laterally, these protrusions rarely remain in the same cell 
quadrant for >2 min and, consequently, the cell randomly oscil-
lates between different states of polarity (Fig. 2 F). This oscilla-
tion correlates with the cell’s seemingly random movement as it 
patrols a small, defi  ned area within the midline.
Pvf2 and -3 act as hemocyte 
chemoattractants in the CNS, 
and Pvf2 acts alone in the dorsal vessel
It has previously been reported that hemocyte developmental 
migrations are dependent on the expression of the PVR tyro-
sine kinase (PVR in hemocytes) and that the three PDGF/VEGF 
ligands—Pvf1, -2, and -3—act redundantly as chemotactic   
factors, directing the migration of hemocytes throughout the 
  embryo (Cho et al., 2002). However, a recent study has sug-
gested that the main role of Pvf signals during hemocyte devel-
opment is to function as survival factors, as hemocyte-specifi  c 
expression of the pan-caspase inhibitor p35 in pvr mutants is 
suffi  cient to largely restore the hemocyte defects normally ob-
served in mutant embryos (Bruckner et al., 2004). Despite these 
results, evidence still exists that Pvf ligands may be acting as 
chemoattractants to hemocytes (Cho et al., 2002). To address 
more thoroughly the role played by Pvf ligands during hemo-
cyte migrations along the ventral midline, we fi  rst observed 
the detailed expression pattern of all three Pvf family mem-
bers within this region of the embryo. Consistent with previ-
ous studies (Cho et al., 2002), we found that Pvf2 and -3, but 
not Pvf1, were expressed in the embryonic ventral midline. 
However, a detailed time course showing the expression pat-
tern within the ventral midline reveals that the timing of expres-
sion of these two genes is different (Fig. 3). Pvf3 is expressed 
along the ventral midline at stage 10, when the germ band is 
fully extended. This expression subsequently decreases and 
is almost undetectable by stage 14 (Fig. 3, K–N). In contrast, 
Pvf2 expression is absent at stage 10 and is only observed from 
stage 12 onward. Expression   appears strongest at stage 14, and 
over the next 2 h of development, RNA levels in the CNS de-
crease in a wave from anterior to posterior such that by stage 15 
Figure 3.  Embryonic expression of Pvf genes. 
In situ hybridization showing the expression 
patterns of Pvf1 (A–E), Pvf2 (F–J), and Pvf3 
(K–O) during embryonic development. (A–D) 
Pvf1 is not expressed within the ventral midline 
at any point during embryogenesis. However, 
strong expression was detected in the tracheal 
cells, caudal ectoderm, malpighian tubules, 
and a posterior ectodermal ring as previously 
reported (Cho et al., 2002). (F–I) No Pvf2 ex-
pression was detected in the ventral midline at 
stage 10 and was only observed from stage 
12 onward. Expression appears strongest at 
stage 14 and, over the next 2 h of develop-
ment, RNA levels decrease in a wave from an-
terior to posterior such that by stage 15 the 
ligand is expressed in small, segmentally reit-
erated points along the posterior region of the 
ventral nerve cord. (K–M) Pvf3 is expressed 
along the ventral midline at stage 10, when 
the germ band is fully extended. This expres-
sion subsequently decreases and falls to almost 
undetectable levels by stage 14. (J) High ex-
pression levels of Pvf2 were also detected in 
the dorsal vessel at stage 14. No such staining 
was observed using probes against Pvf1 (E) or 
Pvf3 (O). Bar, 50 μm.MECHANISMS OF DROSOPHILA HEMOCYTE MIGRATION • WOOD ET AL. 409
the ligand is expressed in small, segmentally reiterated points 
along the posterior region of the ventral nerve cord (Fig. 3, 
F–I). These points of expression correspond to the locations at 
which hemocytes cluster in the midline at this stage (Fig. 2 C). 
We also observed strong expression of Pvf2 in the developing 
dorsal vessel of stage 14 embryos (Fig. 3 J), whereas no expres-
sion of Pvf3 or -1 was detected in this tissue (Fig. 3, E and O). 
To further investigate the role of the Pvf ligands, we analyzed 
in detail hemocyte developmental migrations in pvr mutants. 
As previously described, pvr mutants exhibit a severe hemocyte 
migration defect in which the cells are unable to migrate from 
their origin in the head and undergo apoptosis (Cho et al., 2002; 
Sears et al., 2003). This defect can be rescued by the hemocyte-
specifi  c expression of the pan-caspase inhibitor p35 to prevent 
apoptosis of these cells (Bruckner et al., 2004). We observed 
that these rescued hemocytes not only are unable to infi  ltrate 
the germ band as previously shown (Bruckner et al., 2004) but 
also fail to migrate posteriorly from the head along the CNS and 
the dorsal vessel (Fig. 4, C and D). Because Pvf2 is strongly ex-
pressed in both the ventral nerve cord and the dorsal vessel at the 
same   developmental stages that hemocytes are found   migrating 
along these structures, it seemed likely that Pvf2 acts as a 
chemoattractant to pull hemocytes along these two migration 
routes. To test this hypothesis, we analyzed hemocyte migra-
tion in the pvf2 mutant line vegf27Cb
c6947, a homozygous vi-
able piggyBac[w
+] insertion in the Pvf2 gene (Cho et al., 2002). 
Consistent with a chemotactic role for Pvf2, we found that these 
mutants display a complete absence of hemocytes along the 
dorsal vessel but, curiously, showed only a reduction in hemo-
cyte numbers migrating along the ventral midline (Fig. 4, E and F). 
Because Pvf3 is expressed in the ventral nerve cord at earlier 
stages, we reasoned that these two genes may act redundantly to 
attract hemocytes along the midline. To test for redundancy, we 
used RNAi to inactivate Pvf2 and -3 simultaneously. As a con-
trol, we fi  rst confi  rmed that injection of double-stranded RNA 
(dsRNA) against Pvf2 created the same phenotype as the pvf2 
mutant with injected embryos, displaying a lack of hemocytes 
along the dorsal vessel and reduced numbers of hemocytes on 
the ventral midline (Fig. 4, G and H). Inactivation of Pvf3 alone 
by RNAi had little effect on hemocyte migration (Fig. 4, I and J),
but inactivation of both Pvf2 and -3 prevented hemocyte migra-
tion along both the dorsal vessel and the ventral nerve cord, 
mimicking the phenotype observed in the rescued p35-express-
ing PVR mutant embryos (Fig. 4, K and L).
The pattern of Pvf2 expression during embryogenesis 
coincides spatially and temporally with the migration of 
hemocytes, and our RNAi studies, along with the obser-
vation that ectopic expression of Pvf2 can redirect migration 
Figure 4.  Pvf2 and -3 act redundantly as hemocyte chemoattractants in the CNS, and Pvf2 acts alone in the dorsal vessel. (A and B) srpHemoGAL4UASGFP 
embryos stained with anti-armadillo (red) and anti-GFP (green) antibodies to visualize wild-type hemocyte migration patterns. (A) Dorsal aspect of an embryo 
at stage 14 shows hemocytes migrating posteriorly, along the dorsal vessel (arrows). (B) Ventral aspect of a stage 16 embryo shows hemocytes occupying three 
parallel lines running anterior to posterior along the embryonic ventral midline. (C and D) pvr
1 mutant embryos expressing UAS-p35 and -GFP under the control 
of the hemocyte-speciﬁ  c srpHemoGAL4 driver (Bruckner et al., 2004). (C) Dorsal aspect of a stage 14 embryo shows that although hemocytes are able to 
  migrate away from their origin in the head, no hemocytes are found along the dorsal vessel (arrows) in these mutant embryos. (D) Ventral aspect of a stage 
16 embryo shows that despite expression of p35, pvr
1 mutant hemocytes are completely absent from the ventral midline and only a small number can be seen 
in the more lateral positions (arrow). (E and F) pvf2 mutant embryos (vegf27Cb
c6947) double stained with anti-armadillo (red) and anti-croquemort (green). These 
mutants display a complete absence of hemocytes at the dorsal vessel (E, arrows) but only a slight reduction in hemocyte number at the ventral midline (F). (G–L) 
srpHemoGAL4UASGFP embryos injected with dsRNA against Pvf2 (G and H), Pvf3 (I and J), and Pvf2 and -3 together (K and L). Embryos have been stained 
  using the same antibodies used in A and B. Embryos injected with Pvf2 dsRNA show the same phenotype as the pvf2 mutant (G and H). Injection of Pvf3 dsRNA 
had little effect on hemocyte migration (I and J); however, simultaneous silencing of both Pvf2 and -3 prevented hemocytes migrating along both the dorsal vessel 
(K) and the ventral nerve cord (L), mimicking the phenotype observed in rescued UAS-p35–expressing pvr
1 mutants (compare L and D). Bar, 50 μm.JCB • VOLUME 173 • NUMBER 3 • 2006  410
(Cho et al., 2002), demonstrate this ligand to be operating as 
a hemocyte chemoattractant. The processive down-regulation 
of Pvf2 RNA from anterior to posterior in the ventral midline 
observed between stages 14 and 15 correlates temporally with 
the wave of lateral hemocyte movement occurring during wild-
type development. Because Pvf2 is acting as a chemoattractant 
pulling hemocytes toward the midline, it is possible that the 
decrease in expression of this ligand is responsible for the lateral 
migration of a subset of hemocytes away from the midline. 
To test this hypothesis, we overexpressed Pvf2 in the ventral 
midline using the CNS midline driver single-mindedGal4 
  (simGAL4). Double staining of these embryos with the 
 hemocyte-specifi  c anti-croquemort antibody and anti-armadillo 
showed that the lateral migrations of hemocytes were severely 
disrupted such that at stage 15 of development, few hemocytes 
could be seen occupying more lateral positions (Fig. 5 C), 
demonstrating that a reduction in Pvf2 expression is necessary 
for normal lateral migrations. Interestingly, by stage 16, these 
embryos had recovered the defect, and hemocytes could be 
seen in the usual three lines running anterior to posterior along 
the midline (Fig. 5 D).
Collectively, these data demonstrate that Pvf2 acts as a 
chemoattractant signal whose expression mediates hemocyte 
migration along the dorsal vessel and, together with an earlier 
expression of Pvf3, orchestrates hemocyte migration patterns 
along the CNS during embryogenesis.
Hemocyte chemotaxis toward wounds 
requires actin polymerization 
but is Pvf independent
We have previously shown that embryonic hemocytes rapidly 
chemotax toward an epithelial wound (Stramer et al., 2005) in 
a process resembling the vertebrate infl  ammatory  response. 
To determine whether Pvf signals play a chemotactic role dur-
ing this infl  ammatory response, we made laser ablations to pvr 
mutants expressing p35. 1 h after wounding, these embryos 
show a robust wild-type response from the mutant hemocytes, 
demonstrating that wound chemotaxis is independent of PVR 
expression (Fig. 6, A and B; Rorth, P., personal communication). 
To further study the wound chemotactic response, we devel-
oped a wounding assay using beads that allow the treatment of 
the wound region with inhibitory drugs. Such beads are rou-
tinely used in embryonic studies for the local application of 
chemical inhibitors in vivo (Kawakami et al., 2003). Implanting 
a bead into a D. melanogaster embryo creates an epithelial 
wound approximately the same diameter as the bead (Fig. 6 C). 
As is the case with laser-induced wounds, application of un-
treated beads to a stage 16 embryo leads to rapid accumulation 
of hemocytes at the wound site until, by 30 min, they surround 
the bead (Fig. 6 D). Like unstimulated midline hemocytes, 
these cells exhibit large dynamic membrane ruffl  es and fi  lopo-
dia as they surround and seemingly try to collectively phago-
cytose the invasive bead (Fig. 6 E and Video 2, available at 
http://www.jcb.org/cgi/content/full/jcb.200508161/DC1). These 
actin-rich protrusive structures are one of the most distinctive 
  features of moving cells and are generally considered to be crit-
ical for single-cell migration. To directly test the requirement of 
  cytoskeletal protrusions during hemocyte chemotaxis, we pre-
soaked beads in one of two actin polymerization blocking 
drugs, Cytochalasin D or Latrunculin B, before bead implanta-
tion and examined hemocyte recruitment in embryos 1 h after 
bead insertion. We found that treatment with either drug blocks 
this chemotactic response so that drug-treated beads show little 
or no hemocytes in direct contact with the bead and those he-
mocytes close to the bead exhibit small or no actin protrusions 
and are much less motile when compared with their wild-type 
counterparts (Figs. 6, F and G; and Video 2). In both cases, ef-
fects of drug treatment can be seen up to 50 μm away from the 
bead, as hemocytes that lie further away from the bead exhibit 
normal dynamic lamellipodia (Fig. 6 F). We assume that this 
refl  ects a drop off in drug concentration as a result of drug dif-
fusion away from the bead.
PI3K is not required for developmental 
dispersal but is essential for chemotaxis 
toward wounds
For a hemocyte to chemotax toward a chemotactic source, it has 
to be able to rapidly sense a chemotactic gradient and polarize 
accordingly. Because PI3K has been shown in several systems 
to be a key mediator for cell polarization and directed cell 
Figure 5.  Lateral hemocyte migration at the ventral midline requires a 
down-regulation in Pvf2. (A–D) Embryos double stained with antibodies 
against armadillo (red) and croquemort (green). (A) Ventral aspect of a wild-
type stage 15 embryo shows the normal pattern of hemocyte distribution 
with many cells located in lateral positions (arrows), having migrated away 
from the midline (asterisks). (B) Ventral aspect of a late stage 16 wild-type 
embryo. Hemocytes can clearly be seen in the characteristic three lines run-
ning anterior to posterior along the embryo. (C) Stage 15 embryo in which 
Pvf2 is being overexpressed in the ventral midline using the driver simGAL4. 
Antibody staining shows that the normal hemocyte distribution has been 
drastically disrupted, with only a small number of hemocytes found in lateral 
positions (arrows) and the majority remaining in clumps along the midline 
(asterisks; compare with A). (D) By late stage 16, these simGAL4 UASPvf2 
embryos show normal lateral hemocyte distribution (arrows) and no trace of 
the delay in lateral migration can be seen. Bars, 50 μm.MECHANISMS OF DROSOPHILA HEMOCYTE MIGRATION • WOOD ET AL. 411
  migration (Stephens et al., 2002; Weiner, 2002; Merlot and 
  Firtel, 2003), we tested the requirement of PI3K for the directed 
migration of ventral midline hemocytes during development 
and their chemotaxis toward wounds. Confocal analysis of em-
bryos expressing a dominant-negative form of the D. melano-
gaster PI3K catalytic subunit Dp110
D954A (Leevers et al., 1996), 
specifi  cally in the hemocytes, showed normal hemocyte distri-
bution at all stages of development, and these cells appeared 
morphologically indistinguishable from their wild-type coun-
terparts exhibiting dynamic lamellipodia and fi  lopodia (Fig. 7, 
B, D, and F). The same result was observed when the PI3K in-
hibitor LY294002 was injected into the vitteline space of wild-
type embryos during hemocyte migration (unpublished data). 
To further characterize any possible role for PI3K during these 
developmental migrations, we performed the same quantitative 
tests on the ventral midline hemocytes as on wild type and 
found that Dp110
D954A-expressing hemocytes migrate along the 
ventral midline in a pattern identical to that seen in wild-type 
embryos (unpublished data), demonstrating velocity (while mi-
grating laterally, 1.6 ± 0.5 μm/min [n = 39]), directionality 
(while in midline, 33 ± 17.5% [n = 28], and while migrating 
laterally, 89 ± 8.9% [n = 39]), and polarity (mean lateral pro-
trusive area of 250 vs. 16 μm
2 for the medial side) equal to 
wild-type cells, proving that PI3K is not required for these cells 
to sense and polarize toward the guidance cues that control their 
developmental dispersal.
Though clearly not required for hemocyte developmen-
tal migrations, we wanted to test whether PI3K was required 
for hemocytes to polarize and chemotax toward a wound site. 
To test the involvement of PI3K in this process, we made laser 
ablations in embryos expressing Dp110
D954A in the hemocytes. 
In contrast to the wild-type chemotactic response (Fig. 8 A), the 
mutant cells failed to chemotax toward the wound site and the 
wound remained largely undetected by the hemocytes up to 1 h 
after laser ablation (Fig. 8 B). The same result was obtained 
when beads were implanted in these embryos (Fig. 8 D). 
To ensure that this phenotype was due to a failure in chemotaxis 
and not an indirect result of a reduction in hemocyte survival, 
we counted the number of hemocytes on the ventral side of 
 embryos  expressing  Dp110
D954A. We found no signifi  cant differ-
ence in hemocyte number when compared with wild-type em-
bryos (mean number, 49 ± 9 [n = 17] in Dp110
D954A and 56 ± 8 
[n = 25] in wild type), demonstrating that PI3K plays no sig-
nifi  cant role in hemocyte survival at this stage of development. 
This is consistent with previously published data showing that 
hemocyte-specifi  c expression of Dp110
D954A does not cause the 
hemocyte aggregation that is associated with a decrease in cell 
survival (Bruckner et al., 2004). To further verify our chemo-
taxis result, we implanted two beads into pxnGAL4 UAS-GFP 
embryos in which the hemocytes were expressing GFP but were 
otherwise wild type. In these experiments, one bead was pre-
soaked in the PI3K inhibitor drug LY294002 (Vanhaesebroeck 
Figure 6.  Bead application leads to actin-dependent hemocyte chemotaxis. (A) Differential interference contrast image of a wound made to a UAS-p35–
expressing pvr
1 mutant. (B) Fluorescent image of the same wound as in C shows normal hemocyte numbers at the wound 1 h after laser ablation. Broken 
line indicates wound margin. (C) Implanting a bead  30 μm in diameter into an embryo creates an epithelial wound of the same diameter as seen in an 
E-cadherin–GFP–expressing embryo. (D) When untreated beads are administered to a pxnGAL4 UAS-GFP embryo, a rapid accumulation of hemocytes can 
be seen at the wound site, which surround the bead within 30 min. (E) Hemocytes surrounding a bead presoaked in DMSO exhibit large lamellipodia 
  (arrows) as they actively try to engulf the bead. (F) Bead presoaked in Latrunculin B in DMSO shows a dramatic reduction in number of hemocytes around 
the bead when compared with the control, and those cells near the bead exhibit no lamellipodia (though some rudimentary protrusions can still be seen). 
Hemocytes lying 50 μm away from the bead, however, are able to form lamellipodia (arrow) because of a drop off in drug concentration. (G) Similarly, 
  implantation of a bead soaked in Cytochalasin D in DMSO blocks hemocyte recruitment, and those cells exposed to the drug fail to form large 
actin   protrusions and are consequently unable to migrate (see Video 2, available at http://www.jcb.org/cgi/content/full/jcb.200508161/DC1). 
Bars: (A) 50 μm; (B–G) 20 μm.JCB • VOLUME 173 • NUMBER 3 • 2006  412
and Waterfi  eld, 1999) diluted in DMSO before implantation, 
and the control was presoaked only in DMSO. 1 h after bead 
implantation, as expected, the control DMSO bead was sur-
rounded by hemocytes, demonstrating that DMSO alone does 
not block the chemotactic response of the hemocytes. However, 
no cells chemotaxed toward the bead soaked in PI3K inhibi-
tor (Fig. 8 F). Time-lapse confocal analysis of hemocytes ex-
posed to LY294002 shows that these cells are actively motile 
and able to form large, dynamic actin protrusions that look in-
distinguishable from untreated ventral midline hemocytes that 
have not been exposed to a wound. However, despite appearing 
morphologically normal, they are clearly unable to sense the 
position of the bead and chemotax toward it, even when the 
bead is implanted only 30 μm away from a large population of 
hemocytes (Fig. 8 H and Video 3, available at http://www.jcb.
org/cgi/content/full/jcb.200508161/DC1).
Discussion
In this study, we have analyzed in detail the developmental dis-
persal of hemocytes during embryogenesis. We have found that 
migration of hemocytes along the dorsal vessel requires a che-
motactic Pvf2 signal, and migration along the ventral nerve 
cord is dependent on and orchestrated by chemoattractant sig-
nals from both Pvf2 and -3 expressed in this tissue. It was previ-
ously suggested that the migration routes traversed by all 
hemocytes during development were controlled by all three Pvf 
ligands operating redundantly as guidance cues (Cho et al., 
2002), and our data support a chemotactic role for both Pvf2 
and -3. However, a recent study suggests that the primary role 
of Pvf signaling in embryonic hemocytes is to control anti-
apoptotic cell survival (Bruckner et al., 2004). It is becoming 
clear that Pvf ligands may well act on hemocytes as both 
  chemoattractants and survival factors. This in itself is not a new 
idea, and the close relationship between guidance and survival 
has already been shown to exist in D. melanogaster, where the 
overexpression of the germ cell chemorepellent Wunen causes 
excessive germ cell death (Starz-Gaiano et al., 2001). It remains 
to be seen whether all three Pvf ligands can act as both chemo-
attractants and survival factors or whether each ligand plays a 
different role, with Pvf2 and -3 acting primarily as chemo-
attractants and Pvf1 operating as a survival factor.
Many obvious parallels exist between the migration of he-
mocytes along the ventral midline CNS and another develop-
mentally regulated migration in D. melanogaster, that of border 
cell migration. Border cells take  6 h to migrate a distance of 
100 μm, a speed consistent with that we describe during hemo-
cyte migration along the CNS. Successful border cell migration, 
like hemocyte migration, requires the expression of the Pvr in 
the migrating cells (Duchek et al., 2001) and, just as we see for 
hemocytes, the chemotactic signals detected by the PVR in the 
border cells are not transduced through PI3K (Fulga and Rorth, 
2002). Successful migration of border cells does, however, re-
quire Rac signaling and the Rac activator myoblastcity (mbc), 
the D. melanogaster homologue of Dock 180 (Duchek et al., 
2001). It has been previously shown that hemocyte-specifi  c 
  expression of dominant-negative Rac
N17 disrupts all hemocyte 
developmental migrations, demonstrating that Rac is required 
for the successful migration of ventral midline hemocytes along 
the CNS (Paladi and Tepass, 2004; Stramer et al., 2005). Given 
that Pvr couples to the Dock 180 signaling pathway during border 
cell migration and that Dock 180 has been shown to be involved 
in the migration of lymphocytes (Fukui et al., 2001; Reif and 
Cyster, 2002), Mbc/Dock 180 is a potentially important protein 
for hemocyte migration. Despite the fact that mbc mutant em-
bryos display a grossly normal pattern of hemocyte dispersal 
Figure 7.  Hemocyte developmental dispersal 
does not require PI3K. E-cadherin–GFP; 
crqGAL4 UAS-GFP embryos reveal normal 
hemocyte distribution at stages 12 (A), 14 (C), 
and 16 (E) of development. (B, D, and F) 
  Images showing developmental distribution 
of dominant-negative PI3K (Dp110
D954A)–
  expressing hemocytes. The migrations of the 
dominant-negative–expressing hemocytes are 
indistinguishable from those of the wild type. 
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(Paladi and Tepass, 2004), it would be interesting to look in de-
tail at the migration of these mutant cells along the ventral nerve 
cord. More work is needed to investigate what other similarities 
may exist between border cell migration and ventral midline 
hemocyte migration. During development, only a subset of the 
hemocytes present in the embryo respond to the midline Pvf 
  expression and migrate along the CNS accordingly. Other cells 
follow other migratory pathways. What specifi  es these cells to 
migrate along the midline? Important studies in border cell mi-
gration have shown that the JAK–Stat signaling pathway signal-
ing through the Domeless receptor (Dome) is necessary and 
suffi  cient to transform nonmotile epithelial cells into invasive 
ones (Silver and Montell, 2001; Beccari et al., 2002; Ghiglione 
et al., 2002). Whether a similar signaling mechanism is operat-
ing to specify future ventral midline hemoctyes and initiate their 
migration remains to be seen.
We demonstrate that from stage 14 onwards, once hemo-
cytes occupy the entire ventral midline, individual cells begin to 
rapidly leave the midline and occupy more lateral positions. 
At this stage of development, hemocytes appear to be highly 
polarized, exhibiting large lamellipodia at their leading edges 
and migrating at a speed more than three times faster than their 
earlier midline migration. We have shown that this lateral move-
ment requires a down-regulation in the attractive signal  provided 
Figure 8.  PI3K is required for hemocyte chemotaxis toward wounds. (A) Wound made to a pxnGAL4 UAS-GFP embryo and double stained using antibod-
ies against armadillo (red) and GFP (green) that highlights the homocytes (arrows). (B) The same antibody staining on a wounded embryo expressing 
Dp110
D954A, speciﬁ  cally in the hemocytes, reveals a dramatic decrease in the number of hemocytes at the wound site (arrow). (C) Low-magniﬁ  cation image 
showing a pxnGAL4 UAS-GFP embryo 1 h after bead implantation. The bead (arrow) is surrounded by activated hemocytes. (D) In contrast, when a bead 
(arrow) is implanted in an embryo expressing Dp110
D954A, speciﬁ  cally in the hemocytes, these mutant cells fail to chemotax toward the wound site and 
the bead remains undetected by the hemocytes 1 h after implantation. (E) To verify this result, we implanted two beads into a pxnGAL4 UAS-GFP embryo; 
one bead was untreated (blue) and the other was presoaked in the PI3K inhibitor LY294002 (red). (F) 1 h after bead implantation, the untreated bead 
  (arrowhead) is surrounded by hemocytes, whereas these cells have completely failed to chemotax toward the bead (arrow) soaked in PI3K inhibitor. 
(G) Graph showing mean numbers of hemocytes surrounding implanted beads in wild type, Dp110
D954A-expressing embryos, and drug-treated beads as 
well as numbers of hemocytes present at wild-type laser wounds and wounds made to Dp110
D954A-expressing embryos. Error bars represent SEM. (H) Stills 
from a video showing a bead soaked in LY294002 implanted close to a population of ventral midline hemocytes. The video shows that, although these 
  hemocytes are able to form lamellipodia (arrowhead) and move freely (see Video 3, available at http://www.jcb.org/cgi/content/full/jcb.200508161/DC1), 
they are unable to chemotax toward the bead, and after 1.5 h, only one hemocyte has managed to detect the bead (arrows). Bars: (A, B, and H) 
20 μm; (C–F) 50 μm.JCB • VOLUME 173 • NUMBER 3 • 2006  414
by Pvf2 in the midline, but is this the only driving force for 
the lateral movement? One possibility is that a different source 
of chemoattractant exists in the more lateral positions and 
that once Pvf2 expression is suffi  ciently down-regulated, this 
  chemoattractant source operates to pull hemocytes laterally. 
  Alternatively, hemocytes may be actively repelled from the 
midline or from one another, and the lateral migration observed 
by a subset of these hemocytes is a consequence of these cells 
attempting to maximize the distance between one another while 
maintaining contact with the CNS. It remains to be seen which, 
if any, of these hypotheses is true, but what is certain is that the 
guidance of hemocytes along the ventral midline of the embryo 
is not as simple as was fi  rst thought, and more studies are re-
quired to determine the exact relationship between this subpop-
ulation of hemocytes and the different structures within the 
CNS as well as the overlying ectodermal cells, any of which 
could provide either chemoattractants or repellents for the 
  migrating hemocytes to respond to.
We have demonstrated a requirement of PI3K for the po-
larization and active chemotaxis of hemocytes toward an epi-
thelial wound. This is the fi  rst demonstration of the role of PI3K 
for single-cell chemotaxis in D. melanogaster and shows a 
striking correlation with the mechanism of cell chemotaxis used 
by D. discoideum and mammalian neutrophils (Stephens et al., 
2002; Weiner, 2002; Merlot and Firtel, 2003). In these model 
systems, class I PI3Ks are activated upon stimulation of G pro-
tein–coupled chemoattractant receptors and, once activated, 
PI3Ks catalyze the production of the phosphoinositides PIP3 
and PIP2 at the leading edge of the cell. The accumulation of 
PIP3/PIP2 leads to a rapid and transient recruitment of pleckstrin 
homology domain–containing proteins, including the serine/
threonine kinase Akt/PKB (Funamoto et al., 2001; Wang et al., 
2002). Akt/PKB itself becomes activated upon recruitment to 
the membrane and, in D. discoideum, activates the serine/threonine 
kinase p21-activated kinase a, which eventually leads to the 
phosphorylation of Myosin II and subsequent polarization of 
the cytoskeleton (Chung et al., 2001). Evidence also exists to 
support a role for the PI3K antagonist PTEN in helping to estab-
lish and maintain the intercellular PIP3 gradient required for 
successful chemotaxis by down-regulating the PIP3 pathway at 
the rear of the migrating cell (Funamoto et al., 2002; Iijima and 
Devreotes, 2002). How much of this signaling pathway is oper-
ating in chemotaxing hemocytes remains to be seen. Our cur-
rent study demonstrates the involvement of PI3K, and previous 
work has shown that the small GTPase Rac is required for effi  -
cient hemocyte chemotaxis toward wounds. In neutrophils, PIP3 
production has been shown to be autocatalytic and to require 
Rac but not Cdc42 (Weiner et al., 2002; Srinivasan et al., 2003). 
In the proposed positive feedback loop, it is thought that PIP3 
may stimulate Rac through activation of a specifi  c Rac GEF, 
which in turn activates PI3K, as well as effectors that mediate 
lamellipodial protrusion (Weiner et al., 2002). Because Rac is 
absolutely required for hemocyte chemotaxis and lamellipodia 
formation, it is tempting to speculate that a similar feedback 
loop may be operating in D. melanogaster hemocytes. Further 
work is required to determine the complex relationships oper-
ating among PI3K, Rho family small GTPases, and the actin 
cytoskeleton that coordinate chemotactic migration in these 
highly motile cells.
The PI3K-dependent mechanism of polarization required 
for hemocyte chemotaxis toward a wound is extremely fast and 
perfectly suited for mature, highly motile hemocytes that need 
to rapidly react to a source of attractive signal, be it a wound, an 
invading organism, or an apoptotic cell. In contrast, the me-
chanics to developmentally disperse need not be so rapid, as the 
aim during development is simply to ensure that hemocytes mi-
grate toward and arrive at their target tissue in a given amount 
of time and does not require the rapid response to constantly 
changing environments required for mature hemocytes. The 
mechanism controlling the developmental migration of hemo-
cytes along the ventral midline is consequently much slower 
and is dependent on slow-diffusing growth factors of the Pvf 
family providing short-range guidance information signaling 
through the receptor tyrosine kinase PVR. These two mecha-
nisms may not be the only ways in which hemocytes are able to 
chemotax toward an attractive source; indeed, the observation 
that hemocytes travel different migratory routes in the embryo 
suggests that they may not all be using the same machinery to 
polarize and migrate. What does seem to be consistent for both 
chemotaxis toward developmental signals and toward wounds, 
like motility in many cell types, is a requirement for Rac signal-
ing and the formation of actin protrusions.
The fact that hemocyte migrations within the embryo are 
strictly regulated and adhere to a stereotyped pattern is impor-
tant in a developmental context. Throughout embryogenesis, he-
mocytes carry out important developmental functions within the 
embryo, such as the engulfment and removal of apoptotic cells 
(Franc et al., 1999) and the laying down of many extracellular 
matrix molecules, including collagen IV and laminin, that 
  compose the basement membrane surrounding internal organs 
(Fessler and Fessler, 1989). The failure of hemocytes to travel 
along their normal migratory routes therefore has serious conse-
quences. Such defects have been described in pvr mutants, where 
a lack of hemocyte migration along the ventral nerve cord results 
in a failure in CNS condensation (Olofsson and Page, 2005), as 
well as a disruption in axon patterning (Sears et al., 2003). It is 
therefore vital for the embryo to   ensure that hemocytes arrive at 
their correct target tissues during development. For this to occur, 
it is not suffi  cient to allow these cells to passively disperse 
throughout the embryo by random migrations; instead, a directed 
and tightly controlled migration is required.
In this study, we have locally applied drugs to D. melano-
gaster embryos using bead implantation. The application of drugs 
has been a powerful tool in cell culture and in vitro cell motility 
studies but remains largely unused in D. melanogaster. Using our 
bead assay, we will be able to take advantage of the many useful 
drugs available to block both specifi  c signaling pathways as well 
as important cytoskeletal processes. Combined with the powerful 
genetics available in D. melanogaster and the relative ease of live 
imaging in this system, the study of D. melanogaster hemocytes 
provides a powerful model to address the process of cell motility 
and chemotaxis and will undoubtedly provide a clearer under-
standing of the regulation and mechanics of single-cell migration 
in the complex setting of a multicellular organism.MECHANISMS OF DROSOPHILA HEMOCYTE MIGRATION • WOOD ET AL. 415
Materials and methods
Fly stocks
For live studies, GFP was expressed in hemocytes using either the 
  hemocyte-speciﬁ  c Gal4 line serpentHemoGAL4 (srpHemoGAL4; Bruckner 
et al., 2004) or peroxidasinGAL4 (pxnGAL4; Stramer et al., 2005). To vi-
sualize both hemocytes and epithelial cells, we used a stock homozygous 
for E-cadherin–GFP (Oda et al., 1998) on the second chromosome and 
homozygous for a recombined chromosome carrying both croquemort-
GAL4 (crqGAL4) and UAS-GFP on the third. To drive sufﬁ  cient expression 
of both dominant-negative PI3K and GFP in embryonic hemocytes, w; 
UASDp110
D954A (Leevers et al., 1996) ﬂ  ies were crossed to w; pxnGAL4, 
UAS-GFP; crqGAL4, UAS-GFP ﬂ  ies, generating w; pxnGAL4, UAS-GFP/
UAS-Dp110
D954A ; crqGAL4UAS-GFP/+ progeny. To visualize hemo-
cyte motility in rescued p35-expressing pvr
1 mutant embryos (Bruckner 
et al., 2004), w; pvr
1 srpHemoGAL4 ﬂ  ies were crossed to a w; pvr
1 UAS-
  actinGFP; UAS-p35 stock to generate w; pvr
1 srpHemoGAL4/ pvr
1, UAS-
actinGFP; UAS-p35/+ embryos. For Pvf2 overexpression experiments, 
we crossed w; simGAL4 ﬂ  ies to w; UASPvf2 (also known as Vegf27Cb; 
Cho et al., 2002) and performed antibody stainings on the resulting 
embryos. The Vegf27Cb
c6947 (Cho et al., 2002) line was used for pvf2 
mutant analysis.
Bead implantation
Embryos were dechorionated before being transferred to double-sided 
tape stuck to a slide. Specimens were dehydrated for 6 min before being 
covered with Volatalef oil 10S. Heparin beads (Sigma-Aldrich) or Afﬁ  gel 
blue beads (Bio-Rad Laboratories) were soaked for 3 h in PI3K inhibitor 
LY294002 (Calbiochem) dissolved in DMSO at a concentration of 100 
mM, Latrunculin B (Calbiochem) dissolved in DMSO at a concentration of 
10 mM, or Cytochalasin D (Sigma-Aldrich) dissolved in ethanol at a con-
centration of 10 mM, before being implanted into the embryo using a 
sharpened tungsten needle. Embryos were subsequently mounted under a 
coverslip and imaged.
Live imaging and quantiﬁ  cation
Live imaging was performed using a confocal system (LSM510; Carl Zeiss 
MicroImaging, Inc.) mounted on an Axiovert 100M (Carl Zeiss MicroImag-
ing, Inc.), and the resulting time-lapse series were assembled and analyzed 
using ImageJ imaging software (NIH). Embryos were mounted as previ-
ously described (Wood and Jacinto, 2004), and videos were made at 
room temperature using a Plan-NEOFLUAR 40×/1.3 objective (Carl Zeiss 
MicroImaging, Inc.). Cell tracking was performed using an ImageJ plugin 
(Manual Tracking) on maximum projections of eight slices that represent 
20 μm of the ventral surface of the embryo. For each time point, the center 
of the cell body tracked was manually highlighted, and through its coordi-
nates mean velocity was calculated.
To quantify hemocyte polarity, a straight line was drawn from the 
cell’s departure point within the midline to its arrival point in the lateral 
row. A second line was then drawn perpendicular to the ﬁ  rst, dividing the 
cell into four quadrants. The cell outline was highlighted manually, and the 
cell area within each quadrant was measured using ImageJ software. For 
all quantiﬁ  cation, we deﬁ  ned the start of the lateral movement as the last 
time point the cell was in contact with hemocytes at the midline.
Antibody staining and in situ hybridization
Embryos were ﬁ  xed in 4% formaldehyde and devitellinized before being 
washed with PAT (1% BSA and 0.1% Triton X-100 in PBS). Embryos were 
then transferred to fresh PAT containing mouse anti-armadillo antibody 
(N2 7A1; Developmental Studies Hybridoma Bank) at a 1:50 concentration 
and either rabbit anti-GFP (Abcam) at a 1:1,000 concentration or rabbit 
anti-croquemort (a gift from N. Franc, University College London, London, 
UK) at a 1:500 concentration and rolled overnight at 4°C. After further 
washes in PAT, embryos were incubated for 2 h at room temperature 
in fresh PAT containing Cy3-conjugated donkey anti–mouse and FITC-
conjugated goat anti–rabbit secondary antibodies (Jackson Immuno-
Research Laboratories), each at a dilution of 1:200. After further washes in 
PBT, embryos were mounted on slides using Vectashield and visualized by 
confocal microscopy.
In situ hybridization of whole-mount embryos was performed with 
single-stranded digoxigenin-labeled RNA probes and alkaline phopho-
tase immunochemistry. A 755-bp DNA fragment was generated using 
primers 5′C  G  A  A  A  C  G  C  A  A  A  T  G  G  A  A  T  T  G  T  A  A  A  G  C   and 5′C  T  C  C  G  A  T  T  T  G-
G  C  A  T  C  A  T  T  G  G  G  T  T  C  C  , cloned into pCR-II TOPO vector (Invitrogen) and 
used as a template for Pvf3 probe production. pVegf27Cb (Cho et al., 
2002) was used as a template for Pvf2 probe production, and template 
DNA for Pvf1 probe was a gift from A. Hidalgo (University of Birming-
ham, Birmingham, UK). Embryos were mounted in 50% glycerol and im-
aged using an HC PL FLUOTAR 20×/0.5 objective (Leica). Pictures were 
taken using a camera (DC500; Leica) mounted on a microscope 
(DM5000B; Leica).
RNAi
For the synthesis of Pvf2 dsRNA, a 688-bp region was ampliﬁ  ed  from 
pVegf27Cb (Cho et al., 2002) using the primers 5′T  C  C  A  C  A  T  C  A  C  G  A  G  A-
G  A  A  A  C  G  A  A  C  A  C   and 5′T  T  T  T  G  C  C  A  T  T  C  T  G  A  C  G  T  T  T  T  G  A  C  T  G  . For Pvf3, a 
region of 498 bp was PCR ampliﬁ  ed from pVegf27Ca using primers 5′T  C-
C  A  C  A  T  C  A  C  G  A  G  A  G  A  A  A  C  G  A  A  C  A  C   and 5′T  T  T  T  G  C  C  A  T  T  C  T  G  A  C  G  T  T  T  T-
G  A  C  T  G  . Primer pairs also contained the T7 promoter sequence at their 5′ 
ends. The PCR products were used as templates for the T7 transcription re-
actions with the T7 RiboMax large scale production kit (Promega). The 
dsRNA was dissolved in injection buffer at a ﬁ  nal concentration of 2 μg/μl 
and injected into 0–1-h hold w; srpHemoGal4UASGFP embryos. When 
both dsRNAs were injected, the concentration of each was kept at 2 μg/μl. 
Injected embryos were left to develop at 25°C, ﬁ  xed in 4% formaldehyde 
before being hand devitellinized, and stained using antibodies as 
  described above.
Online supplemental material
Video 1 shows wild-type hemocyte migration at the embryonic ventral mid-
line. Video 2 shows the effect of Cytochalasin D on hemocyte chemotaxis 
toward wounds. Video 3 demonstrates the effect of the PI3K inhibitor 
LY294002 on the same process. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200508161/DC1.
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